Testosterone Replacement with 1% Testosterone Gel and Priapism: No Definite Risk Relationship

ConclusionsSafety data from the clinical trials for AndroGel 1% did not report any cases of priapism, and its incidence in the postmarketing pharmacovigilance data is extremely low, indicating a minimal risk of inducing priapism.

Source: The Journal of Sexual Medicine - January 24, 2013 Category: Sexual Medicine Authors: Arthur L. Burnett, Natalia Kan‐Dobrosky, Michael G. Miller Tags: ORIGINAL RESEARCH Source Type: research